In a recent meta-analysis published in Cancer Medicine, researchers evaluated the impact of cognitive-behavioral treatment (CBT) on the mental health (MH) and quality of life (QoL) of cancer patients.
Cancer affects millions globally, and while treatments improve longevity and survival rates, they also affect the physical, psychological, and social well-being of cancer patients.
Affected individuals often experience depression, anxiety, and decreased wellness, which can persist even after treatment. Addressing these concerns is crucial for the long-term well-being of cancer patients.
CBT is a widely used treatment for mental health disorders like depression and anxiety that enhances quality of life and reduces disease relapse. However, its effectiveness on cancer survivors remains limited. While CBT effectively treats distress, pain, insomnia, fatigue, fear, anxiety, and depression in cancer, its combined effectiveness in treating mental health and general wellness remains unclear.